These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 792846)

  • 21. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E; Alfani D; Monari C; Trovati A; Berloco P; Famulari A; Cucchiara G; Cortesini R
    Minerva Chir; 1980 May; 35(10):747-50. PubMed ID: 7005730
    [No Abstract]   [Full Text] [Related]  

  • 22. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
    Hourmant M; Buzelin F; Dubigeon P; Soulillou JP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenous use of high dosage of ALG.
    Brendel W
    Laval Med; 1970 Feb; 41(2):255-9. PubMed ID: 4929502
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of antilymphocyte globulin in renal allograft rejection. A controlled study.
    Birkeland SA
    Postgrad Med J; 1976; 52(5 Suppl):82-8. PubMed ID: 792853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antilymphoblast globulin in renal transplant patients. No allergic reactions.
    Martin WJ; Blumenthal M; Roitman B; Condie R; Simmons R; Najarian J
    JAMA; 1976 Oct; 236(15):1729-31. PubMed ID: 61287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low incidence of rejection and in vitro donor-specific hyporesponsiveness using pretransplant ALG, low-dose cyclosporine, and steroids in kidney cadaveric transplantation.
    Griñó JM; Bas J; Gonzalez C; Castelao AM; Seron D; Mestre M; Buendia E; Sabate R; Diaz C; Alsina J
    Transplant Proc; 1990 Aug; 22(4):1367-8. PubMed ID: 2143855
    [No Abstract]   [Full Text] [Related]  

  • 27. Experience with antilymphocyte globulin in 144 renal transplant recipients.
    Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE
    Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of intravenous route for administration of antilymphocyte globulins in humans.
    Traeger J; Touraine JL; Fries D; Berthoux F
    Transplant Proc; 1971 Mar; 3(1):749-53. PubMed ID: 4937966
    [No Abstract]   [Full Text] [Related]  

  • 29. Complications related to the route of Minnesota antilymphoblast globulin administration in renal transplant recipients.
    Ludwin D; White N; Tsai S; Orovan W; Smith EK
    Transplant Proc; 1985 Aug; 17(4):1945-6. PubMed ID: 3895636
    [No Abstract]   [Full Text] [Related]  

  • 30. New experiences with antilymphocyte globulin in human organ transplantation.
    Largiadér F; Ruckert R
    Postgrad Med J; 1976; 52(5 Suppl):79-81. PubMed ID: 792852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single center experience of the effect of delayed function on outcome in retransplant recipients of cadaveric renal allografts.
    Langley J; Vergne-Marini P; Dickerman RM; Brinker KR; Land G
    Transplant Proc; 1991 Apr; 23(2):1757-9. PubMed ID: 2053145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-lymphocytic globulin in canine renal allotransplantation. I. Histologic and immunohistologic findings for two preparations given by subcutaneous and intravenous routes.
    Collste LG; Wasserman J; Bergstrand A; Groth CG
    Acta Chir Scand; 1972; 138(7):655-60. PubMed ID: 4566003
    [No Abstract]   [Full Text] [Related]  

  • 33. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB; Mercer DF; Grant WJ; Freifeld AG; Lane JT; Groggel GC; Rigley TH; Nielsen KJ; Henning ME; Skorupa JY; Skorupa AJ; Christensen KA; Sandoz JP; Kellogg AM; Langnas AN; Wrenshall LE
    Transplantation; 2008 May; 85(10):1391-9. PubMed ID: 18497677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different aspects of antilymphocyte globulin (ALG) treatment in man.
    Brendel W
    Br J Surg; 1969 Aug; 56(8):621. PubMed ID: 4894619
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-thymocytic globulin in canine renal allotransplantation. II. Immunosuppressive and toxic effect with subsutaneous and intravenous administration.
    Collste LG
    Acta Chir Scand; 1972; 138(7):661-6. PubMed ID: 4566004
    [No Abstract]   [Full Text] [Related]  

  • 36. [Renal transplantation. Clinical experience with antilymphocyte serum].
    Traeger J; Fries D
    J Urol Nephrol (Paris); 1969 Dec; 75(12):Suppl 12:200+. PubMed ID: 4989751
    [No Abstract]   [Full Text] [Related]  

  • 37. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute rejection episodes after renal transplantation in children.
    Hoyer PF; Offner G; Brodehl J
    Clin Nephrol; 1983 Feb; 19(2):61-6. PubMed ID: 6340876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of tolerance to antilymphocyte globulin in man.
    Weksler ME; Bull G; Schwartz GH; Stenzel KH; Rubin AL
    Transplant Proc; 1971 Mar; 3(1):754-7. PubMed ID: 4937967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.